• SIGN IN
  • GET HELP
  •  

    Webinar Details


    Event Type

    Live Online

    Date

    Wednesday, September 25, 2019

    Time

    10:30 AM - 11:45 AM ET

    Location

    PharmCon Webinar Studio (freeCE.com)

    Credits

    1.25 Contact Hour(s)

    Target Audience

    Pharmacist, Nurse

    Cost

    $30.00

    • Overview

      The release of the PARADIGM-HF study and approval of sacubitril/valsartan provided a new treatment option (ARNIs) that could lead to better outcomes for patients with heart failure. This activity will provide an overview of the currently recommended morbidity and mortality-reducing agents for patients with heart failure. It will summarize key clinical trials that have led to the current recommendations for medication use in heart failure, with specific emphasis on the evidence around the use of ARNIs, and the role these could play in future heart failure management.

      Rating

         4.75  out of 5


      Handouts

      Slide Document 17162L01_4pp.pdf
      Slide Document 17162L01_2pp.pdf





      Financial Support By

      PharmCon
    • Pharmacist

      List the medications currently considered standard of care for patients with heart failure
      Summarize key evidence that supports current standards of care for patients with heart failure
      Describe the mechanism and role of angiotensin receptor/neprilysin inhibitors (ARNIs) in heart failure

      Nurse

      List the medications currently considered standard of care for patients with heart failure
      Summarize key evidence that supports current standards of care for patients with heart failure
      Describe the mechanism and role of angiotensin receptor/neprilysin inhibitors (ARNIs) in heart failure
    • Repeat Presentation

      This presentation was last given on 9/25/2019 10:30 AM

      Future Airings

      Date Time
      Friday, January 10, 2020 10:30 AM View

    • Activity Type

      Knowledge

      CE Broker

      20-580445

      Universal Activity Number

      Pharmacist 0798-0000-17-162-L01-P

      Nurse 0798-0000-17-162-L01-P

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, attendees must answer poll questions and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.


    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).




    Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.